HN2001000011A - Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos. - Google Patents

Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos.

Info

Publication number
HN2001000011A
HN2001000011A HN2001000011A HN2001000011A HN2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A
Authority
HN
Honduras
Prior art keywords
eteres
diabetes
preparation
treatment
methods
Prior art date
Application number
HN2001000011A
Other languages
English (en)
Spanish (es)
Inventor
Ando Howard Yoshihisa
Butler Donald Eugene
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HN2001000011A publication Critical patent/HN2001000011A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HN2001000011A 2000-01-25 2001-01-24 Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos. HN2001000011A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
HN2001000011A true HN2001000011A (es) 2001-06-13

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000011A HN2001000011A (es) 2000-01-25 2001-01-24 Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos.

Country Status (39)

Country Link
EP (1) EP1259474B1 (cg-RX-API-DMAC7.html)
JP (1) JP4750995B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020073182A (cg-RX-API-DMAC7.html)
CN (1) CN1395555A (cg-RX-API-DMAC7.html)
AP (1) AP2002002587A0 (cg-RX-API-DMAC7.html)
AR (1) AR029436A1 (cg-RX-API-DMAC7.html)
AT (1) ATE431326T1 (cg-RX-API-DMAC7.html)
AU (1) AU2214001A (cg-RX-API-DMAC7.html)
BG (1) BG106851A (cg-RX-API-DMAC7.html)
BR (1) BR0107763A (cg-RX-API-DMAC7.html)
CA (1) CA2397960C (cg-RX-API-DMAC7.html)
CO (1) CO5261537A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20022474A3 (cg-RX-API-DMAC7.html)
DE (1) DE60138686D1 (cg-RX-API-DMAC7.html)
DK (1) DK1259474T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ3239A1 (cg-RX-API-DMAC7.html)
EA (1) EA004862B1 (cg-RX-API-DMAC7.html)
EE (1) EE200200404A (cg-RX-API-DMAC7.html)
ES (1) ES2324281T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20053428B (cg-RX-API-DMAC7.html)
GT (1) GT200100015A (cg-RX-API-DMAC7.html)
HN (1) HN2001000011A (cg-RX-API-DMAC7.html)
HU (1) HUP0204422A3 (cg-RX-API-DMAC7.html)
IL (1) IL150541A0 (cg-RX-API-DMAC7.html)
IS (1) IS6442A (cg-RX-API-DMAC7.html)
MA (1) MA26867A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02007223A (cg-RX-API-DMAC7.html)
NO (1) NO20023526L (cg-RX-API-DMAC7.html)
NZ (1) NZ519550A (cg-RX-API-DMAC7.html)
OA (1) OA12166A (cg-RX-API-DMAC7.html)
PA (1) PA8510601A1 (cg-RX-API-DMAC7.html)
PE (1) PE20011064A1 (cg-RX-API-DMAC7.html)
PL (1) PL357076A1 (cg-RX-API-DMAC7.html)
SK (1) SK10622002A3 (cg-RX-API-DMAC7.html)
SV (1) SV2002000290A (cg-RX-API-DMAC7.html)
TN (1) TNSN01013A1 (cg-RX-API-DMAC7.html)
UY (1) UY26550A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001055078A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200205880B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
KR20050058454A (ko) * 2002-08-22 2005-06-16 워너-램버트 캄파니 엘엘씨 골관절염의 치료 방법
CA2605331A1 (en) * 2005-04-19 2006-11-02 Eisai R & D Management Co., Ltd. Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
CA3059073A1 (en) * 2017-04-18 2018-10-25 Daniela Carmen Oniciu Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
EP3867222A4 (en) * 2018-10-18 2022-07-06 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
CN1395555A (zh) 2003-02-05
EP1259474B1 (en) 2009-05-13
CO5261537A1 (es) 2003-03-31
IL150541A0 (en) 2003-02-12
CA2397960A1 (en) 2001-08-02
OA12166A (en) 2003-11-07
JP2003520835A (ja) 2003-07-08
NO20023526D0 (no) 2002-07-24
UY26550A1 (es) 2001-08-27
PE20011064A1 (es) 2001-10-22
TNSN01013A1 (fr) 2005-11-10
EE200200404A (et) 2003-10-15
ATE431326T1 (de) 2009-05-15
ZA200205880B (en) 2003-07-23
MXPA02007223A (es) 2002-11-29
DE60138686D1 (de) 2009-06-25
NZ519550A (en) 2003-11-28
MA26867A1 (fr) 2004-12-20
GT200100015A (es) 2001-10-19
SV2002000290A (es) 2002-07-16
CZ20022474A3 (cs) 2003-06-18
AP2002002587A0 (en) 2002-09-30
SK10622002A3 (sk) 2003-07-01
NO20023526L (no) 2002-08-27
IS6442A (is) 2002-06-25
CA2397960C (en) 2008-09-09
PA8510601A1 (es) 2002-08-26
EA200200641A1 (ru) 2002-12-26
ES2324281T3 (es) 2009-08-04
HUP0204422A3 (en) 2003-08-28
WO2001055078A1 (en) 2001-08-02
DZ3239A1 (fr) 2001-08-02
HUP0204422A2 (en) 2003-05-28
KR20020073182A (ko) 2002-09-19
JP4750995B2 (ja) 2011-08-17
EA004862B1 (ru) 2004-08-26
BG106851A (en) 2003-01-31
PL357076A1 (en) 2004-07-12
AU2214001A (en) 2001-08-07
AR029436A1 (es) 2003-06-25
BR0107763A (pt) 2002-11-12
DK1259474T3 (da) 2009-07-20
GEP20053428B (en) 2005-01-25
EP1259474A1 (en) 2002-11-27

Similar Documents

Publication Publication Date Title
PA8609201A1 (es) Piridinonas sustituidas
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
UY30407A1 (es) Derivados de [2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-8-il]-fenil sulfonatos sustituidos, composiciones farmacéuticas y aplicaciones.
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
AR014261A1 (es) Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion
ES8106124A1 (es) Un procedimiento para la pre-paracion de fenoxialcoxifenil- derivados.
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
DE60021873D1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
HN2001000011A (es) Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos.
ATE491453T1 (de) Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges
MXPA03004347A (es) Nuevos derivados de imidazol, metodo de produccion y uso de los mismos.
CO5180630A1 (es) Nuevos analogos de 2-decarboxi-2-fosfinico prostaglandina f.
AR061433A1 (es) Compuestos de amida del acido 3-amino-tieno (2,3,b) piridina -2-carboxilico sustituido, procesos para su preparacion y usos de los mismos
CR8275A (es) 2-CARBONILAMINO-6-PIPERIDINAMINOPIRIDINAS SUSTITUIDAS Y 1-CARBONILAMINO-3- PIPERIDINAMINOBENZENOS SUSTITUIDOS COMO 5-HT1f AGONISTAS
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
ATE179168T1 (de) Substituierte spiroverbindungen zur behandlung von entzündungen
BR0312586A (pt) Derivados de pirolidina como antagonistas e oxitocina
UY26666A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
ES8300332A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazoquinazolinas
ES2169399T3 (es) Procedimiento para preparar heterociclos de fenilo utiles como inhibidores de la cox-2.
UY25841A1 (es) Cicloheptenos sustituidos y su procedimiento de obtencion
DE60209122D1 (de) Bernsteinsäurederivate
ES8307803A1 (es) Procedimiento de preparar trimetoxibenzoatos de apovincaminol substituidos con efecto inhibidor de las fosfodiestebasas.